Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
NCT03316651
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Alveolar Proteinosis
Treatment
Interventions
DRUG:
GM-CSF
Sponsor
Dai Huaping